IFP Advisors, Inc - Santen Pharmaceutical Co Ltd ownership

Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 6 filers reported holding Santen Pharmaceutical Co Ltd in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of Santen Pharmaceutical Co Ltd
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2019$6,0000.0%4020.0%0.00%0.0%
Q1 2016$6,0004020.00%
Other shareholders
Santen Pharmaceutical Co Ltd shareholders Q1 2021
NameSharesValueWeighting ↓
QUADRANT CAPITAL GROUP LLC 6,116$85,0000.02%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 917,927$13,691,0000.01%
IFP Advisors, Inc 402$6,0000.00%
GLENMEDE TRUST CO NA 3,056$45,0000.00%
Lenox Wealth Advisors, LLC 94$1,0000.00%
Private Capital Group, LLC 159$2,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 458$7,0000.00%
View complete list of Santen Pharmaceutical Co Ltd shareholders